Jeffrey P. Townsend

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Epistasis plays a limited role in driving entrenchment during neutral protein evolution

  Genome biology · 2026-06-17

• Empowering Inference of Epistasis on the Basis of Mutual Exclusivity, Co‐Occurrence, Functional Antagonism and Synergy in <scp>ERK</scp> ‐Pathway Oncogenes

  International Journal of Cancer · 2026-06-08

• IP36-13 ADDING UPFRONT, PERIOPERATIVE DURVALUMAB VERSUS ADOPTING RISK-ADAPTED ADJUVANT NIVOLUMAB? COST-EFFECTIVENESS ANALYSIS OF COMPETING TREATMENT STRATEGIES FOR CISPLATIN-ELIGIBLE MUSCLE-INVASIVE BLADDER CANCER IN THE ERA OF IMMUNE CHECKPOINT INHIBITORS

  The Journal of Urology · 2026-04-27

• Signal, noise, and bias in phylogenetic inference: potential and limits to the resolution of phylogenetic trees in the phylogenomic era

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-04-01

• Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment

  Journal of the National Comprehensive Cancer Network · 2026-03-23 · 1 citations

• DMEM and EMEM as alternate growth media for pathogenic Leptospira

  PLoS neglected tropical diseases · 2026-03-17

• Figure S11 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Data from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S16 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Table S5 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S13 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Table S1 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S12 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S3 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Table S4 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S5 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S9 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S1 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Figure S8 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02

• Table S3 from Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer

  2026-03-02